Form D · Biotechnology
ARGOS THERAPEUTICS INC
Durham, NC · CIK 0001105533
Offering snapshot reported Aug 27, 2013 · SEC filing
- Reported sold
- $22M Offering amount: $60M
- Investors reported
- 25 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 9, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 27, 2013 | Initial | $22,007,404 | No comparison | 25 | SEC filing |
| Sep 11, 2012 | Initial | $15,978,125 | No comparison | 24 | SEC filing |
| Apr 24, 2012 | Initial | $9,021,875 | No comparison | 30 | SEC filing |
| Jul 29, 2011 | Initial | $3,500,000 | No comparison | 29 | SEC filing |
| Sep 20, 2010 | Initial | $4,852,074 | No comparison | 27 | SEC filing |
| May 9, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-201905
Source: Form D, filed Aug 27, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jeffrey D. Abbey | Director, Executive |
| Hubert Birner | Director |
| B. Jefferson Clark | Director |
| Michel Greco | Director |
| David Gryska | Director |
| Lori Harrelson | Executive |
| Ines Holzbaur | Director |
| Monique Laliberte | Director |
| Jean Lamarre | Director |
| Frederick M. Miesowicz | Executive |
| Charles A. Nicolette | Executive |
| Andrei Petrov | Director |
| Douglas Plessinger | Executive |
| Philip R. Tracy | Director |
| Brian Underdown | Director |
| Sander Van Deventer | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4233 Technology Dr
Durham, NC, 27704
Durham, NC, 27704